Peer Review channel feed

Amy­lyx hires new CMO from Ul­tragenyx; Eliot Forster is back as a CEO af­ter F-star sale

3 days ago

De­sign Ther­a­peu­tics hints at ‘strate­gic re­align­ment,’ re­places CEO; Karyopharm co-founder leads AT­P's Nereid

3 weeks ago

Cen­tu­ry Ther­a­peu­tics nabs Bris­tol My­ers alum as CEO; En­her­tu star Dai­ichi Sankyo makes changes in Eu­rope

4 weeks ago

CNS biotech Rap­port snags a CFO vet­er­an from Karuna; Bris­tol My­ers’ new CEO to chair the board next year

Last month

Flag­ship's Mon­tai Health hires first CMO; Fi­nance leader to re­tire at J&J part­ner Xen­cor

Last month

Co-found­ed by David Bak­er, Vilya rings in a per­ma­nent CEO; Al­lo­gene names Er­ic Schmidt's CFO suc­ces­sor

Last month

Po­sei­da pro­motes cell ther­a­py pres­i­dent to CEO; Af­ter IPO, Neumo­ra ap­points R&D chief

Last month

Dave Lennon's CEO ad­ven­ture goes from pre­clin­i­cal to com­mer­cial; GSK vet em­barks on new Odyssey with Gary Glick

Last month
People

Ex­clu­sive: For­mer Genen­tech duo re­unites to push Sono­ma in­to the clin­ic; Ex-Ma­gen­ta com­mer­cial chief heads to Ed­i­tas

2 months ago

Mark Vel­le­ca takes over at Black Di­a­mond; Verve Ther­a­peu­tics sep­a­rates CMO, CSO posts

2 months ago

Phil Vick­ers talks new role as head of Long­wood’s Solu af­ter Faze shut­down; Re­gen­eron CFO to re­tire in Feb­ru­ary

2 months ago

Glyscend taps CEO to lead oral obe­si­ty, type 2 di­a­betes can­di­date; Ex-Travec­ta chief bounces back af­ter com­pa­ny shut­down

2 months ago

David Khougaz­ian joins Flag­ship to build ‘part­ner­ships with dif­fer­ent fla­vors’; For­mer No­vo Nordisk ex­ec to lead Evax­ion

3 months ago

Bay­er en­lists Jür­gen Eck­hardt to leap in­to an ad­di­tion­al role; Mi­rati tops list of mul­ti­ple CFO ex­its

3 months ago

Flag­ship re­cruits ex-Ma­gen­ta CEO to lead Am­per­sand; Bio­gen's head of re­search leaves for All­tr­na

3 months ago

Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

3 months ago

Brent Saun­ders keeps rolling out the changes at Bausch + Lomb; In­cyte CSO to ex­it next month

4 months ago

Cyrus Moza­yeni fol­lows ADC 'bea­con' to Pheon CEO role; BeiGene los­es busi­ness chief to Te­va

4 months ago

Ex­clu­sive: Af­ter Cure­Vac, Ig­or Splaws­ki moves to RTW stealth start­up; Lyn­dra's Jes­si­ca Ballinger adds CEO ti­tle amid com­mer­cial prep

4 months ago

Deb­o­rah Birx en­ters new phase as biotech CEO; Ve­rastem chief an­nounces his re­tire­ment

4 months ago

Lynn Seely brings ex-My­ovant col­league to Lyel­l's C-suite; Nkar­ta, Zai Lab name new CFOs

5 months ago

Ex-Gala­pa­gos med­ical chief heads to uniQure; Mar­tin Mack­ay lines up Rally­bio suc­ces­sor

5 months ago

Se­bas­t­ian Guth sharp­ens his fo­cus at Bay­er; As CD47 strug­gles per­sist, I-Mab ap­points CEO

5 months ago

Ex-Metacrine chief Pre­ston Klassen recharges at mi­croR­NA biotech; Al­lo­gene be­gins search for a CFO

5 months ago
1234 Next page Last page
A service from the Financial Times